Bruno RR, Wolff G, Kelm M, Jung C. Pharmacological treatment of cardiogenic shock - a state of the art review. Pharmacol Ther. 2022;240:108230. https://doi.org/10.1016/j.pharmthera.2022.108230.
Article CAS PubMed Google Scholar
Sinha SS, Rosner CM, Tehrani BN, Maini A, Truesdell AG, Lee SB, Bagchi P, Cameron J, Damluji AA, Desai M, et al. Cardiogenic shock from heart failure versus acute myocardial infarction: clinical characteristics, hospital course, and 1-year outcomes. Circ Heart Fail. 2022;15:e009279. https://doi.org/10.1161/circheartfailure.121.009279.
Article CAS PubMed Google Scholar
Krychtiuk KA, Vrints C, Wojta J, Huber K, Speidl WS. Basic mechanisms in cardiogenic shock: part 1-definition and pathophysiology. Eur Heart J Acute Cardiovasc Care. 2022;11:356–65. https://doi.org/10.1093/ehjacc/zuac021.
Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol. 2019;74:2117–28. https://doi.org/10.1016/j.jacc.2019.07.077.
Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD, Ferrari R, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19:1242–54. https://doi.org/10.1002/ejhf.890.
Scheen M, Giraud R, Bendjelid K. Stress hyperglycemia, cardiac glucotoxicity, and critically ill patient outcomes current clinical and pathophysiological evidence. Physiol Rep. 2021;9:e14713. https://doi.org/10.14814/phy2.14713.
Article CAS PubMed PubMed Central Google Scholar
Bagate F, Lellouche N, Lim P, Moutereau S, Razazi K, Carteaux G, de Prost N, Dubois-Randé JL, Brun-Buisson C, Mekontso DA. Prognostic value of relative adrenal insufficiency during cardiogenic shock: a prospective cohort study with long-term follow-up. Shock. 2017;47:86–92. https://doi.org/10.1097/shk.0000000000000710.
Ducrocq N, Biferi P, Girerd N, Latar I, Lemoine S, Perez P, Thivilier C, Levy B, Kimmoun A. Critical illness-related corticosteroid insufficiency in cardiogenic shock patients: prevalence and prognostic role. Shock. 2018;50:408–13. https://doi.org/10.1097/shk.0000000000001090.
Article CAS PubMed Google Scholar
Tol MM, Shekar K, Barnett AG, McGree J, McWhinney BC, Ziegenfuss M, Ungerer JP, Fraser JF. A preliminary investigation into adrenal responsiveness and outcomes in patients with cardiogenic shock after acute myocardial infarction. J Crit Care. 2014;29(470):e471-476. https://doi.org/10.1016/j.jcrc.2014.01.020.
Nussinovitch U, de Carvalho JF, Pereira RM, Shoenfeld Y. Glucocorticoids and the cardiovascular system: state of the art. Curr Pharm Des. 2010;16:3574–85. https://doi.org/10.2174/138161210793797870.
Article CAS PubMed Google Scholar
MacLeod C, Hadoke PWF, Nixon M. Glucocorticoids: fuelling the fire of atherosclerosis or therapeutic extinguishers? Int J Mol Sci. 2021;22:7622. https://doi.org/10.3390/ijms22147622.
Article CAS PubMed PubMed Central Google Scholar
Liu B, Zhang TN, Knight JK, Goodwin JE. The Glucocorticoid receptor in cardiovascular health and disease. Cells. 2019;8:1227. https://doi.org/10.3390/cells8101227.
Article CAS PubMed PubMed Central Google Scholar
Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, Briegel J, Carcillo J, Christ-Crain M, Cooper MS, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43:1751–63. https://doi.org/10.1007/s00134-017-4919-5.
Yao TC, Huang YW, Chang SM, Tsai SY, Wu AC, Tsai HJ. Association between oral corticosteroid bursts and severe adverse events : a nationwide population-based cohort study. Ann Intern Med. 2020;173:325–30. https://doi.org/10.7326/m20-0432.
Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ, Nallamothu BK. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. Bmj. 2017;357:j1415. https://doi.org/10.1136/bmj.j1415.
Article PubMed PubMed Central Google Scholar
Liu C, Liu G, Zhou C, Ji Z, Zhen Y, Liu K. Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance. Can J Cardiol. 2007;23:865–8. https://doi.org/10.1016/s0828-282x(07)70840-1.
Article CAS PubMed PubMed Central Google Scholar
Liu C, Liu K. Cardiac outcome prevention effectiveness of glucocorticoids in acute decompensated heart failure: COPE-ADHF study. J Cardiovasc Pharmacol. 2014;63:333–8. https://doi.org/10.1097/fjc.0000000000000048.
Article CAS PubMed Google Scholar
Aslam R, Ducrocq N, Thivilier C, Perez P, Gerard A, Kimmoun A, Levy B. Critical illness-related corticosteroid insufficiency in cardiogenic shock. Br J Anaesth. 2013;111:512–3. https://doi.org/10.1093/bja/aet271.
Article CAS PubMed Google Scholar
Wolff B, Machill K, Schulzki I, Schumacher D, Werner D. Acute reversible cardiomyopathy with cardiogenic shock in a patient with Addisonian crisis: a case report. Int J Cardiol. 2007;116:e71-73. https://doi.org/10.1016/j.ijcard.2006.07.207.
Mekontso-Dessap A, Marrache D, Vieillard-Baron A. Images in cardiology: acute adrenal insufficiency complicated by cardiogenic shock. Heart. 2005;91:e31. https://doi.org/10.1136/hrt.2004.055095.
Article CAS PubMed PubMed Central Google Scholar
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200. https://doi.org/10.1093/eurheartj/ehw128.
Miró Ò, Takagi K, Gayat E, Llorens P, Martín-Sánchez FJ, Jacob J, Herrero-Puente P, Gil V, Wussler DN, Richard F, et al. CORT-AHF study: effect on outcomes of systemic corticosteroid therapy during early management acute heart failure. JACC Heart Fail. 2019;7:834–45. https://doi.org/10.1016/j.jchf.2019.04.022.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495–9. https://doi.org/10.1016/j.ijsu.2014.07.013.
Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. Bmj. 2021;374:n1380. https://doi.org/10.1136/bmj.n1380.
Abdin A, Pöss J, Fuernau G, Ouarrak T, Desch S, Eitel I, de Waha S, Zeymer U, Böhm M, Thiele H. Correction to: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol. 2018;107:531. https://doi.org/10.1007/s00392-018-1225-3.
Shah AD, Bartlett JW, Carpenter J, Nicholas O, Hemingway H. Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study. Am J Epidemiol. 2014;179:764–74. https://doi.org/10.1093/aje/kwt312.
Article PubMed PubMed Central Google Scholar
Huang YH, Cai WK, Yin SJ, Wang P, Li ZR, Yang Q, Zhou T, Meng R, Yang M, Guo Y, et al. Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study. Eur J Prev Cardiol. 2022;29:1854–65. https://doi.org/10.1093/eurjpc/zwac122.
González Ariza A, ArandoArbulu A, León Jurado JM, Navas González FJ, Delgado Bermejo JV, Camacho Vallejo ME. Discriminant canonical tool for differential biometric characterization of multivariety endangered hen breeds. Animals. 2021;11:2211. https://doi.org/10.3390/ani11082211.
Article PubMed PubMed Central Google Scholar
Vandewalle J, Libert C. Glucocorticoids in sepsis: to be or not to be. Front Immunol. 2020;11:1318. https://doi.org/10.3389/fimmu.2020.01318.
Article CAS PubMed PubMed Central Google Scholar
Metra M, Chioncel O, Cotter G, Davison B, Filippatos G, Mebazaa A, Novosadova M, Ponikowski P, Simmons P, Soffer J, et al. Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock - a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC). Eur J Heart Fail. 2022;24:1967–77. https://doi.org/10.1002/ejhf.2629.
Article CAS PubMed Google Scholar
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368.
Article CAS PubMed Google Scholar
Bagate F, Coppens A, Masi P, de Prost N, Carteaux G, Razazi K, Mekontso DessapA. Cardiac and vascular effects of low-dose steroids during the early phase of septic shock: an echocardiographic study. Front Cardiovasc Med. 2022;9:948231. https://doi.org/10.3389/fcvm.2022.948231.
Article CAS PubMed PubMed Central Google Scholar
Li S, Zhao Q, Zhen Y, Li L, Mi Y, Li T, Liu K, Liu C. The impact of glucocorticoid therapy on guideline-directed medical treatment titration in patients hospitalized for heart failure with low blood pressure: a retrospective study. Int J Gen Med. 2021;14:6693–701. https://doi.org/10.2147/ijgm.S334132.
Article CAS PubMed PubMed Central Google Scholar
Chan ED, Chan MM, Chan MM, Marik PE. Use of glucocorticoids in the critical care setting: Science and clinical evidence. Pharmacol Ther. 2020;206:107428. https://doi.org/10.1016/j.pharmthera.2019.107428.
留言 (0)